Related Experiment Video
Updated: Sep 10, 2026

Methods for Electroporation and Transformation Confirmation in Limosilactobacillus reuteri DSM20016
Published on: June 23, 2023
Rewiring lactobacilli: challenges, opportunities, and the translational path to therapeutics
Varun Sai Tadimarri1, Marc Blanch-Asensio2, Shrikrishnan Sankaran2
1INM - Leibniz Institute for New Materials, Saarland University, Campus D2 2, Saarbrücken 66123, Germany; Chemistry Department, Saarland University, Saarbrücken 66123, Germany.
Abstract:
Lactobacilli have long been regarded as promising probiotic bacteria due to their safety profile, host compatibility, and beneficial roles in modulating human health. However, the therapeutic efficacy of wild-type probiotics remains constrained by limited target specificity, lack of control over their activity, and variability in clinical responses. Recent advances in synthetic biology have enabled the possibility of overcoming these constraints through precise engineering of bacterial functions, such as therapeutics production. Despite these advances, significant challenges remain in engineering lactobacilli, including limited genetic toolkits, species- and strain-dependent variability, and uncertainty regarding the stability and safety of engineered strains. This review discusses the current landscape of engineering lactobacilli for therapeutic applications, with particular emphasis on candidates undergoing clinical evaluation. Furthermore, it outlines key technical hurdles to overcome and suggests potential solutions to accelerate their translation into clinically effective and reliable microbial therapeutics.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Bioreactor Controls-III
Coordination of Gene Expression Processes in Bacteria
Production of Antibiotics
Production of Pharmaceuticals
Microbiota Modulation by Antibiotics
